Skip to main content
Donna Culton, MD, Dermatology, Chapel Hill, NC

Donna Aline Culton MD PhD (She/Her)


Associate Professor, Dermatology, University of North Carolina at Chapel Hill School of Medicine

Join to View Full Profile
  • 410 Market StSuite 400Chapel Hill, NC 27516

  • Phone+1 919-966-2485

  • Fax+1 919-966-6460

Dr. Culton is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of North Carolina Hospitals
    University of North Carolina HospitalsResidency, Dermatology, 2007 - 2010
  • Cone Health
    Cone HealthInternship, Internal Medicine, 2006 - 2007
  • University of North Carolina at Chapel Hill School of Medicine
    University of North Carolina at Chapel Hill School of MedicineClass of 2006

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 2006 - 2026
  • Dermatology
    American Board of Dermatology Dermatology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2014, 2016-2017
  • CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2014, 2016-2017
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2014, 2016-2017

Publications & Presentations

PubMed

Lectures

  • Pemphigus and Pemphigoid: Evidence-based Updates 
    American Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/3/2019

Press Mentions

  • Reviewers' List December 2019
    Reviewers' List December 2019August 23rd, 2019
  • Syntimmune Announces Positive Preliminary Results from Clinical Proof-of-Concept Trial of SYNT001 in Pemphigus Vulgaris and Foliaceus
    Syntimmune Announces Positive Preliminary Results from Clinical Proof-of-Concept Trial of SYNT001 in Pemphigus Vulgaris and FoliaceusJune 4th, 2018
  • Targeted Therapies Create Urgency for Early Diagnosis of Pemphigus and Pemphigoid
    Targeted Therapies Create Urgency for Early Diagnosis of Pemphigus and PemphigoidFebruary 6th, 2026

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: